Skip to main content
Figure 2 | BMC Pediatrics

Figure 2

From: Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France

Figure 2

Sensitivity analyses: Expansion of newborn screening to include MCADD vs. current newborn screening. The width of the bar indicates the variation in the incremental cost-effectiveness ratio associated with alternative parameter values for that input. The numbers on the right side, next to the parameters, indicate the lower- and upper-bounds of the ranges used in sensitivity analyses.

Back to article page